|
Quotes & Info
|
| IMUC > SEC Filings for IMUC > Form 8-K on 5-Mar-2013 | All Recent SEC Filings |
5-Mar-2013
Results of Operations and Financial Condition, Financial Statem
On March 5, 2013, ImmunoCellular Therapeutics, Ltd. (the "Company") issued a press release announcing financial results for the year and quarter ended December 31, 2012. A copy of this press release is attached hereto as Exhibit 99.1.
This information, including exhibits attached hereto and the information under Item 7.01 below, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
99.1 Press Release dated March 5, 2013
99.2 Condensed Financial Statements
|
|